Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 2 |
Citigroup
C
|
+$374M |
| 3 |
Amazon
AMZN
|
+$352M |
| 4 |
XL
XL Group Ltd.
XL
|
+$284M |
| 5 |
PPG Industries
PPG
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$288M |
| 2 |
Union Pacific
UNP
|
+$283M |
| 3 |
JPMorgan Chase
JPM
|
+$238M |
| 4 |
AGN
Allergan plc
AGN
|
+$226M |
| 5 |
Archer Daniels Midland
ADM
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 8.85% |
| 2 | Financials | 7.52% |
| 3 | Industrials | 6.64% |
| 4 | Energy | 5.78% |
| 5 | Technology | 5.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4451
PUT
Ingredion
INGR
$6.63B
| $560K | ﹤0.01% |
6,600
-7,600
| -54% | -$604K |
|
4452
Omega Healthcare
OHI
$14.1B
| $560K | ﹤0.01% |
14,335
+14,225
| +12,932% | +$539K |
|
|
SYT
4453
DELISTED
Syngenta Ag
SYT
| $560K | ﹤0.01% |
8,715
-1,456
| -14% | -$91.8K |
|
|
CZR
4454
CALL
DELISTED
Caesars Entertainment Corporation
CZR
| $560K | ﹤0.01% |
35,700
-600
| -2% | -$8.03K |
|
4455
PUT
Pan American Silver
PAAS
$19.7B
| $559K | ﹤0.01% |
60,800
-133,400
| -69% | -$1.33M |
|
4456
Colgate-Palmolive
CL
$73.3B
| $558K | ﹤0.01% |
8,060
-303,739
| -97% | -$20.5M |
|
4457
Hawaiian Electric Industries
HE
$2.03B
| $558K | ﹤0.01% |
16,666
-42,392
| -72% | -$1.23M |
|
4458
Middleby
MIDD
$5.33B
| $558K | ﹤0.01% |
5,632
-2,346
| -29% | -$215K |
|
4459
CALL
Acadia Healthcare
ACHC
$2.87B
| $557K | ﹤0.01% |
9,100
+4,300
| +90% | +$250K |
|
4460
PUT
Clean Harbors
CLH
$17B
| $557K | ﹤0.01% |
11,600
+6,100
| +111% | +$297K |
|
4461
Haverty Furniture Companies
HVT
$449M
| $557K | ﹤0.01% |
+25,334
| New | +$544K |
|
4462
iShares MSCI BIC ETF
BKF
$76.5M
| $556K | ﹤0.01% |
15,882
+7,369
| +87% | +$270K |
|
4463
PUT
Logitech
LOGI
$14.8B
| $556K | ﹤0.01% |
41,400
+18,200
| +78% | +$249K |
|
|
WCC
4464
CALL
WESCO International
WCC
$17.6B
| $556K | ﹤0.01% |
7,300
-3,900
| -35% | -$307K |
|
|
WIN
4465
PUT
DELISTED
Windstream Holdings Inc
WIN
| $556K | ﹤0.01% |
8,617
-7,137
| -45% | -$546K |
|
4466
iShares Emerging Markets Dividend ETF
DVYE
$1.21B
| $555K | ﹤0.01% |
+13,262
| New | +$577K |
|
4467
ProShares Ultra Russell2000
UWM
$251M
| $555K | ﹤0.01% |
24,528
-7,556
| -24% | -$156K |
|
|
CST
4468
CALL
DELISTED
CST Brands, Inc.
CST
| $554K | ﹤0.01% |
12,700
+1,200
| +10% | +$48.2K |
|
4469
PUT
Boston Properties
BXP
$10.9B
| $553K | ﹤0.01% |
4,300
-5,300
| -55% | -$671K |
|
|
LCI
4470
PUT
DELISTED
Lannett Company, Inc.
LCI
| $553K | ﹤0.01% |
3,225
+1,325
| +70% | +$246K |
|
|
XLRN
4471
CALL
DELISTED
Acceleron Pharma
XLRN
| $553K | ﹤0.01% |
14,200
+7,800
| +122% | +$272K |
|
|
MACK
4472
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $553K | ﹤0.01% |
6,228
-14,019
| -69% | -$1.02M |
|
4473
CALL
Ball Corp
BALL
$16.4B
| $552K | ﹤0.01% |
16,200
-12,200
| -43% | -$402K |
|
4474
Renaissance IPO ETF
IPO
$165M
| $552K | ﹤0.01% |
+24,190
| New | +$556K |
|
4475
Madrigal Pharmaceuticals
MDGL
$11.7B
| $552K | ﹤0.01% |
5,950
+4,746
| +394% | +$491K |
|
Similar funds
Ken Griffin's Q4 2014 Portfolio in Review
As of Q4 2014, Ken Griffin held 9,167 positions worth $102B, up 6.5% from $95.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Ken Griffin's Q4 2014 filing shows 1,076 new, 3,582 increased, 3,580 reduced and 702 closed positions. Its largest new stake was SIGMA - ALDRICH CORP: 1,469,606 shares worth $202M. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $288M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 8.8% of assets, up from 7.6% a quarter earlier, followed by Financials and Industrials.
- Ken Griffin's largest Q4 2014 buy was SIGMA - ALDRICH CORP: 1,469,606 shares worth $202M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2014, an estimated $1.04B increase.
- Ken Griffin's biggest Q4 2014 reduction was Union Pacific, cutting an estimated $283M.
- Ken Griffin fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2014, selling an estimated $288M.
- Ken Griffin's ten largest holdings make up 16% of its $102B portfolio in Q4 2014.
- Ken Griffin opened 1,076 new positions and closed 702 in Q4 2014.
- Ken Griffin's portfolio value rose 6.5% quarter-over-quarter to $102B.
Based on Citadel Advisors's 13F filing for Q4 2014, filed 17 Feb 2015.